Canada
· Delayed Price · Currency is CAD Aptose Biosciences Statistics
Total Valuation
TSX:APS has a market cap or net worth of CAD 6.73 million. The enterprise value is 13.19 million.
| Market Cap | 6.73M |
| Enterprise Value | 13.19M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:APS has 2.14 million shares outstanding. The number of shares has increased by 210.45% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.14M |
| Shares Change (YoY) | +210.45% |
| Shares Change (QoQ) | +91.58% |
| Owned by Insiders (%) | 0.37% |
| Owned by Institutions (%) | 11.51% |
| Float | 1.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.36 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.25 |
Financial Position
The company has a current ratio of 2.14
| Current Ratio | 2.14 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.30 |
| Interest Coverage | -126.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -141.98% |
| Return on Invested Capital (ROIC) | -779.60% |
| Return on Capital Employed (ROCE) | -463.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.81M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.91% in the last 52 weeks. The beta is 1.21, so TSX:APS's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +86.91% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 1.22 |
| Relative Strength Index (RSI) | 47.27 |
| Average Volume (20 Days) | 8,614 |
Short Selling Information
The latest short interest is 6,975, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 6,975 |
| Short Previous Month | 10,084 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.78M |
| Pretax Income | -36.59M |
| Net Income | -36.59M |
| EBITDA | -37.73M |
| EBIT | -37.78M |
| Earnings Per Share (EPS) | -52.35 |
Balance Sheet
The company has 8.85 million in cash and 15.31 million in debt, giving a net cash position of -6.46 million or -3.01 per share.
| Cash & Cash Equivalents | 8.85M |
| Total Debt | 15.31M |
| Net Cash | -6.46M |
| Net Cash Per Share | -3.01 |
| Equity (Book Value) | -6.54M |
| Book Value Per Share | -3.26 |
| Working Capital | 7.30M |
Cash Flow
In the last 12 months, operating cash flow was -51.77 million and capital expenditures -7,194, giving a free cash flow of -51.77 million.
| Operating Cash Flow | -51.77M |
| Capital Expenditures | -7,194 |
| Free Cash Flow | -51.77M |
| FCF Per Share | -24.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:APS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -210.45% |
| Shareholder Yield | -210.45% |
| Earnings Yield | -543.67% |
| FCF Yield | -769.26% |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Feb 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |